Calcium and vitamin D supplementation in an unexpected light: a case study review Case report
Article Sidebar
Main Article Content
Abstract
The article presents three clinical cases of patients with osteoporosis and overlapping chronic conditions (osteoarthritis, obesity, hypertension, chronic pain syndromes) to illustrate an optimal model for long-term treatment. Maintaining high adherence over extended therapy remains a primary objective, necessitating consideration of drug interactions, potential side effects, and patient preferences. This paper highlights the importance of supplements and over-the-counter (OTC) medications that patients often take independently, without informing their healthcare providers. A thorough patient history should also include these preparations as a foundation for effective pain management and calcium and vitamin D3 supplementation.
Article Details
Copyright © by Medical Education. All rights reserved.
References
2. Samborski W, Sikorska D, Niklas A et al. NLPZ a powikłania sercowo-naczyniowe i gastroenterologiczne – algorytm wyboru. Forum Reumatol. 2018; 4(3): 143-51.
3. da Costa BR, Reichenbach S, Keller N et al. Effectiveness of non-steroidal anti-inflammatory drugs for the treatment of pain in knee and hip osteoarthritis: a network meta-analysis. BMJ. 2021; 375: n232.
4. Balk EM, Adam GP, Langberg VN et al. Global dietary calcium intake among adults: a systematic review. Osteoporos Int. 2017; 28: 3315-24.
5. Qaseem A, Hicks LA, Etxeandia-Ikobaltzeta I et al.; Clinical Guidelines Committee of the American College of Physicians. Pharmacologic Treatment of Primary Osteoporosis or Low Bone Mass to Prevent Fractures in Adults: A Living Clinical Guideline From the American College of Physicians. Ann Intern Med. 2023; 176(2): 224-38.
6. Płudowski P, Kos-Kudła B, Walczak M et al. Guidelines for Preventing and Treating Vitamin D Deficiency: A 2023 Update in Poland. Nutrients. 2023; 15: 695.
7. Badurski J. Osteoporoza a złamania. Przewodnik zrozumienia diagnostyki i leczenia. Blackhorse, 2003.
8. Głuszko P, Sewerynek E, Misiorowski W et al. Guidelines for the diagnosis and management of osteoporosis in Poland. Update 2022. Endokrynol Pol. 2023; 74(1): 5-15.
9. Bruyère O, Honvo G, Veronese N et al. An updated algorithm recommendation for the management of knee osteoarthritis from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Semin Arthritis Rheum. 2019; 49(3): 337-50.
10. Zeng C, Wei J, Persson MSM et al. Relative efficacy and safety of topical non-steroidal anti-inflammatory drugs for osteoarthritis: a systematic review and network meta-analysis of randomised controlled trials and observational studies. Br J Sports Med. 2018; 52(10): 642-50.
11. McEvoy L, Carr DF, Pirmohamed M. Pharmacogenomics of NSAID-Induced Upper Gastrointestinal Toxicity. Front Pharmacol. 2021; 12: 684162.